Drug profile · INN
adefovir dipivoxil
HEPSERA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
adefovir dipivoxil (HEPSERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN adefovir dipivoxil
Brand HEPSERA
Route ORAL
Formulation TABLET
ATC code J05AF08
Frequently asked questions
What is adefovir dipivoxil?
adefovir dipivoxil (HEPSERA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for adefovir dipivoxil?
HEPSERA is a marketed brand name for adefovir dipivoxil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of adefovir dipivoxil?
adefovir dipivoxil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.